Differences of clinical characteristics and outcome in proven invasive Trichosporon infections caused by asahii and non‐asahii species

Abstract

AbstractBackgroundTrichosporon is an emerging yeast that causes invasive infections in immunocompromised patients experiencing prolonged hospitalisation, indwelling venous catheters and neutropenia.MethodsThis retrospective observational cohort study analysed invasive Trichosporon infections (ITIs) occurring between January 2005 and December 2022 at three tertiary hospitals and compared the clinical characteristics and prognostic factors of ITIs caused by Trichosporon asahii and non‐T. asahii spp. After evaluating 1067 clinical isolates, we identified 46 patients with proven ITIs, defined as cases in which Trichosporon was isolated from blood, cerebrospinal fluid, or sterile tissues.ResultsThe patients were separated into T. asahii and non‐T. asahii groups containing 25 and 21 patients, respectively, all of which except one were immunocompromised. During this period, both the number of clinical isolates and patients with ITIs (mainly T. asahii) increased; whereas, cases involving non‐T. asahii spp. decreased. Compared with the non‐T. asahii group, the T. asahii group had more patients with multiple catheters (84% vs. 33%, p = .001) and those receiving renal replacement therapy (48% vs. 14%, p = .005). The all‐cause 28‐day mortality rate after ITI in the T. asahii group (44%) was significantly higher than in the non‐T. asahii group (10%, Log‐rank p = .014). The multivariate Cox regression model revealed that T. asahii (reference, non‐T. asahii spp.; aHR = 4.3; 95% CI = 1.2–15.2, p = .024) and neutropenia for 5 days or more (aHR = 2.2, 95% CI = 1.5–3.6, p = .035) were independent factors in the 28‐day mortality after ITI.ConclusionThe proven ITIs due to T. asahii produced more unfavourable outcomes compared with ITIs caused by non‐T. asahii spp.